Clinical Trials
771 trialsChemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer
Peking Union Medical College Hospital
A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients
Kalbe International Pte. Ltd
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
PILLAR
Jules Bordet Institute
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
Qurgen Inc.
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies
L-Nutra Inc
MTTRIHPW
Obstetrics & Gynecology Hospital of Fudan University
PEACOCC
University College, London
LIBRE-2
Technical University of Munich
A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd.
A Novel Smart Speculum Versus a Standard Speculum for Easy Visualisation of the Cervix and Performing Remote Cervical Cancer Screening
GICMED
Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer
The First Hospital of Jilin University
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
PANO
Dublin City University
FERTILAVE
Hospices Civils de Lyon
Pemb-HT
University Health Network, Toronto
Study on TIL for the Treatment of r/r Gynecologic Tumors
Shanghai 10th People's Hospital
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
ImmVira Pharma Co. Ltd
DCE-MRI
University Hospital, Ghent
PROVIDENCE
Hospital Clinic of Barcelona
Romantic
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
PITHAC
Centre Hospitalier Universitaire Vaudois
Nab-PIPAC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
GARD-HIPEC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
CECIL
University of Santo Tomas Hospital, Philippines
Preventing Ovarian Cancer Through Oportunistic Salpingectomy at the Time of Colorectal Surgery
University of British Columbia
NIECE
Assistance Publique - HĂ´pitaux de Paris
POSVUC
Sahlgrenska University Hospital
VUBAR
Universitair Ziekenhuis Brussel
Management With Fear of Cancer in Women Undergoing Colposcopy: Randomized Controlled Study
Alanya Alaaddin Keykubat University
Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer--ACTN4 and Other Biomarkers in Menstrual Blood
WomenX Biotech Limited
Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer-HPV DNA and Other Biomarkers in Urine
WomenX Biotech Limited
Family History Study on Cancer Risk
Kaiser Permanente
VICTORIA
Centre Leon Berard
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
BENITA
Universitätsklinikum Hamburg-Eppendorf
SENTIREC II
University of Southern Denmark
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions
Catalysis SL
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Celon Pharma SA
Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)
Catalysis SL
Effects of Decision Aids on the Participation of South Asian Women in Cervical Cancer Screening
Chinese University of Hong Kong
Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer
Shantou University Medical College
Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors
Peking Union Medical College Hospital
Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer
Peking Union Medical College Hospital
HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor
HRYZ Biotech Co.
Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer
University Health Network, Toronto
A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure
Zhejiang Cancer Hospital
A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors
Shanghai Huaota Biopharmaceutical Co., Ltd.